Cardiomyocyte stiffness in diastolic heart failure
Attila Borbély1, Jolanda van der Velden, Zoltán Papp
1Laboratory for Physiology, Institute for Cardiovascular Research, VUMC, Amsterdam, The Netherlands.
Insights
Diastolic heart failure (DHF) involves stiffer heart muscle cells, leading to impaired relaxation. Reduced protein phosphorylation may cause this stiffness, which can be reversed by protein kinase A (PKA).
Area of Science:
- Cardiology
- Molecular Biology
- Biophysics
Background:
- Diastolic heart failure (DHF), characterized by preserved left ventricular ejection fraction (EF), is increasingly recognized.
- The exact pathogenetic mechanisms of DHF are not fully understood due to limited myocardial biopsy material.
- This study analyzed endomyocardial biopsy samples from DHF patients to investigate myocardial characteristics.
Purpose of the Study:
- To analyze collagen volume fraction (CVF) and sarcomeric protein composition in DHF patients.
- To assess cellular contractile performance of isolated cardiomyocytes from DHF patients.
- To correlate myocardial properties with in vivo diastolic dysfunction.
Main Methods:
- Endomyocardial biopsy samples from DHF patients and controls were analyzed for CVF.
- Single cardiomyocytes were isolated and their contractile performance assessed.
- Mechanically isolated cardiomyocytes were activated with varying calcium concentrations to measure isometric force and resting tension (F(passive)).
Main Results:
- DHF patients exhibited higher CVFs compared to controls.
- Cardiomyocytes from DHF patients showed significantly higher resting tension (F(passive)) despite similar maximal force development.
- F(passive) and CVF together correlated better with elevated LV end-diastolic pressure (LVEDP) than either parameter alone.
Conclusions:
- DHF is associated with stiffer cardiomyocytes, evidenced by increased passive tension at a given sarcomere length.
- Increased F(passive) and CVF are key determinants of diastolic dysfunction in DHF.
- The ability of protein kinase A (PKA) to reduce F(passive) suggests reduced sarcomeric protein phosphorylation plays a role in DHF pathogenesis.
Background:
Heart failure with preserved left ventricular (LV) ejection fraction (EF) is increasingly recognized and usually referred to as diastolic heart failure (DHF). Its pathogenetic mechanism remains unclear, partly because of a lack of myocardial biopsy material. Endomyocardial biopsy samples obtained from DHF patients were therefore analyzed for collagen volume fraction (CVF) and sarcomeric protein composition and compared with control samples. Single cardiomyocytes were isolated from these biopsy samples to assess cellular contractile performance.
Methods And Results:
DHF patients (n=12) had an LVEF of 71+/-11%, an LV end-diastolic pressure (LVEDP) of 28+/-4 mm Hg, and no significant coronary artery stenoses. DHF patients had higher CVFs (7.5+/-4.0%, P<0.05) than did controls (n=8, 3.8+/-2.0%), and no conspicuous changes in sarcomeric protein composition were detected. Cardiomyocytes, mechanically isolated and treated with Triton X-100 to remove all membranes, were stretched to a sarcomere length of 2.2 microm and activated with solutions containing varying [Ca2+]. Compared with cardiomyocytes of controls, cardiomyocytes of DHF patients developed a similar total isometric force at maximal [Ca2+], but their resting tension (F(passive)) in the absence of Ca2+ was almost twice as high (6.6+/-3.0 versus 3.5+/-1.7 kN/m2, P<0.001). F(passive) and CVF combined yielded stronger correlations with LVEDP than did either alone. Administration of protein kinase A (PKA) to DHF cardiomyocytes lowered F(passive) to control values.
Conclusions:
DHF patients had stiffer cardiomyocytes, as evident from a higher F(passive) at the same sarcomere length. Together with CVF, F(passive) determined in vivo diastolic LV dysfunction. Correction of this high F(passive) by PKA suggests that reduced phosphorylation of sarcomeric proteins is involved in DHF.
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy


